As of August 28, 2026, Perspective Therapeutics, Inc. (CATX) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Perspective Therapeutics, Inc. has a market capitalization of $449.34M, 114.15M shares outstanding, 137 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $500.00M.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise
model 18%
• Active ATM program with $500M remaining capacity
Market Data
Market Cap$449.34M
Shares Outstanding114.15M
Float74.34M
Cash$236.88M
Debt$1.60M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 161.9% shares (2026Q1 vs prior)
137 institutional holders · 98.36M shares
#1
Avidity Partners Management LP
12.10M shares
#2
MORGAN STANLEY
10.22M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
8.76M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest23.47M
Days to Cover25.6
% of Float31.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2018-06-30
4
INSIDER TRANSACTION
2026-03-04
4
INSIDER TRANSACTION
2026-03-04
4
INSIDER TRANSACTION
2026-03-04
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CATX Dilution Snapshot
Perspective Therapeutics, Inc. (CATX) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $500.0M.
- Recent SEC activity tracked for CATX: 4 on 2026-03-04; 4 on 2026-03-04; 4 on 2026-03-04.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CATX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CATX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CATX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.